The MedMemos Study: Promoting Adherence to Medications in Pediatric Bone Marrow Transplant Patients
Recruiting
N/A
Interventional Study
Hematopoietic Cell Transplant
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 0 – 12
- Sex
- Any
- Study type
- Interventional
- Purpose
- Supportive Care
- Participants needed
- 25 (estimated)
- Sponsor
- Nationwide Children's Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this clinical trial is to test the MedMemos Intervention with parents and children who have received a bone marrow transplant. The main study questions are:
* Is the MedMemos intervention acceptable to patients and families?
* Is the MedMemos intervention feasible for patients, families, and healthcare providers?
* Does MedMemos help patients and families take their medications better…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Child had a Pediatric Allogeneic Hematopoietic Cell Transplant (PAHCT)
* Child is 0-12 years of age
* At the time of recruitment child is still in the hospital for PAHCT
* Child's primary caregiver is responsible for administering medical care and is willing to give consent to…
Contacts